Regeneron Pharmaceuticals, Inc. (REGN) — SC 13G/A Filings

SC 13G/A Filings (5)

• Vanguard Amends Regeneron Stake: Holds 7.6% as of Dec 29, 2023 — Feb 13, 2024 Risk: low
  The Vanguard Group, a major investment firm, filed an amendment to its Schedule 13G on February 13, 2024, disclosing its ownership in Regeneron Pharmaceuticals
• Capital World Investors Trims Regeneron Stake to 4.7% — Feb 9, 2024 Risk: low
  Capital World Investors, a major institutional investor, filed an amended SC 13G/A on February 9, 2024, disclosing a slight decrease in its beneficial ownership
• FMR LLC Reports 9.63% Stake in Regeneron Pharma — Feb 9, 2024 Risk: low
  FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have updated their ownership stake in Regeneron Pharmaceuticals Inc. As of Decemb
• BlackRock Amends Regeneron Stake; Passive Investment Update — Jan 25, 2024
  BlackRock Inc. filed an amended Schedule 13G/A on January 25, 2024, indicating a change in its ownership of Regeneron Pharmaceuticals Inc. common stock as of De
• JPMorgan Amends Regeneron Stake; Passive Ownership Update — Jan 25, 2024
  JPMorgan Chase & Co. filed an amended Schedule 13G/A on January 25, 2024, indicating a change in its beneficial ownership of Regeneron Pharmaceuticals, Inc. com

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX